Assessment of Disease Control Status in Hypertension and Type 2 Diabetes Mellitus Patients Coming for Medication Report Renewal and Home Blood Pressure Measurement Habits in Hypertension Patients

Yıl 2026, Cilt: 9 Sayı: 1, 126 - 131, 17.03.2026

Ayşenur Uçar , Mehmet Erdevir

https://izlik.org/JA49FF74NP

Öz

Objective: In this study, the disease control status of patients who came to renew their medication reports was compared with that of patients who visited for follow-up, and home blood pressure measurement habits were evaluated in hypertensive patients.
Materials and Methods: The records of outpatients who visited the Internal Medicine Outpatient Clinic-13 of Adana Yüreğir State Hospital between 1 January and 14 February 2025 were retrospectively reviewed. A total of 1,774 patient files were screened, and 389 patients with hypertension and 367 patients with type 2 diabetes were identified. Patients were divided into two groups based on their reason for presentation: those who came to renew their medication prescriptions and those who came for follow-up. Hypertension was considered controlled if systolic blood pressure was <130 mmHg and diastolic blood pressure was <80 mmHg. Type 2 diabetes was considered controlled in patients with fasting blood sugar ≤130 mg/dl and HbA1c ≤7%.
Results: 36.8% of hypertension patients came to renew their medication reports, and 15.9% came for follow-up. The habit of measuring blood pressure at home was 34.3% in the report renewal group and 54.8% in the control group (p<0.05). Hypertension control was similar and low in both groups (28.7% and 27.5%, p=0.85). Among patients with type 2 diabetes, 36.5% applied for report renewal and 23.4% for follow-up. The rate of diabetes control was 30.6% in the report renewal group and 39.5% in the follow-up group (p=0.172).
Conclusion: The rates of follow-up visit attendance and disease control were low in both disease groups and most patients visited the hospital only to get a medication report.

Anahtar Kelimeler

Hypertension , Type 2 Diabetes , Home blood pressure monitoring

İlaç Raporu Yenilemeye Gelen Hipertansiyon ve Tip 2 Diabetes Mellitus Hastalarında Hastalık Kontrol Durumları ile Hipertansiyon Hastalarında Evde Kan Basıncı Ölçme Alışkanlıklarının Değerlendirilmesi

https://izlik.org/JA49FF74NP

Öz

Yöntem: Adana Yüreğir Devlet Hastanesi İç Hastalıkları Polikliniği-13’e 01 Ocak - 14 Şubat 2025 tarihleri arasında ayaktan başvuran hastaların kayıtları retrospektif olarak incelendi. Toplam 1774 hasta dosyası tarandı, 389 hipertansiyon ve 367 tip 2 diyabet hastası tespit edildi. Hastalar başvuru nedenlerine göre ilaç raporu yenilemek için gelenler ve kontrol için gelenler olarak iki gruba ayrıldı. Hipertansiyon için sistolik kan basıncı <130 mmHg ve diyastolik kan basıncı <80 mmHg olanların hastalığı kontrol altında kabul edildi. Tip 2 Diyabet için açlık kan şekeri ≤130 mg/dl ve HbA1c ≤%7 olanların hastalığı kontrol altında kabul edildi
Bulgular: Hipertansiyon hastalarının %36,8'i ilaç raporu yenileme, %15,9'u kontrol amacıyla başvurmuştu. Evde kan basıncı ölçümü alışkanlığı rapor yenileme grubunda %34,3, kontrol grubunda %54,8 idi (p<0,05). Hipertansiyonun kontrol altında olması her iki grupta da benzer ve düşük bulundu (%28,7 ve %27,5, p=0,85). Tip 2 diyabet hastalarının %36,5'i rapor yenileme, %23,4'ü kontrol için başvurmuştu. Diyabet için kontrol altında olma oranı rapor yenileme grubunda %30,6, kontrol grubunda %39,5 idi (p=0,172).
Sonuç: Her iki hastalık grubunda da takip ziyaretlerine katılım ve hastalık kontrol oranları düşüktü ve çoğu hasta sadece ilaç raporu almak için hastaneye başvurduğu görüldü.

Anahtar Kelimeler

Hipertansiyon , Tip 2 Diyabet , Evde kan basıncı takibi

Kaynakça

• Sosyal Güvenlik Kurumu. Sağlık Uygulama Tebliği. Resmî Gazete. 2013;(28597):17229. Erişim tarihi: 7 Haziran 2025. https://mevzuat.gov.tr/mevzuat?MevzuatNo=17229&MevzuatTur=9&MevzuatTertip=5
• Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169-180. Crossref
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. Hypertension. 2018;71(6):1269-1324. Crossref
• Türkiye Endokrinoloji ve Metabolizma Derneği. Hipertansiyon Tanı ve Tedavi Kılavuzu 2022. 6. baskı. Ankara:
• Türkiye Endokrinoloji ve Metabolizma Derneği Obezite, Dislipidemi, Hipertansiyon Çalışma Grubu; 2022.
• McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018. Crossref
• Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34(6):1208-1217. Crossref
• Abaci A, Oguz A, Kozan O, Toprak N, Senocak H, Deger N, et al. Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study). J Hum Hypertens. 2006;20(5):355-361. Crossref
• T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Kronik Hastalıklar ve Yaşlı Sağlığı Daire Başkanlığı Dokümanlar. Erişim tarihi: 7 Haziran 2025. https://hsgm.saglik.gov.tr/tr/dokumanlar-kronikhastaliklar.html
• Türkiye Endokrinoloji ve Metabolizma Derneği Diyabet Bilimsel Çalışma Grubu. Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu 2024. 16. baskı. Ankara: Türkiye Endokrinoloji ve Metabolizma Derneği; 2024. Erişim tarihi: 26 Haziran 2024. https://file.temd.org.tr/Uploads/publications/guides/documents/diabetesmellitus2024.pdf
• McManus RJ, Little P, Stuart B, Morton K, Raftery J, Kelly J, et al; HOME BP Investigators. Home and online management and evaluation of blood pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ. 2021;372:m4858. Crossref
• Andraos J, Munjy L, Kelly MS. Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations. Blood Press. 2021;30(4):220-229. Crossref
• Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al; American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2022;79(1):e1-e14. Crossref
• Mahmood S, Jalal Z, Hadi MA, Shah KU. Association between attendance at outpatient follow-up appointments and blood pressure control among patients with hypertension. BMC Cardiovasc Disord. 2020;20(1):458. Crossref
• Huang QF, Yang WY, Asayama K, Zhang ZY, Thijs L, Li Y, et al. Ambulatory blood pressure monitoring to diagnose and manage hypertension. Hypertension. 2021;77(2):254-264. Crossref
• Gondi S, Ellis S, Gupta M, Ellerbeck E, Richter K, Burns J, et al. Physician perceived barriers and facilitators for self-measured blood pressure monitoring: a qualitative study. PLoS One. 2021;16(8):e0255578. Crossref
• Dhungana RR, Pedisic Z, de Courten M. Implementation of non-pharmacological interventions for the treatment of hypertension in primary care: a narrative review of effectiveness, cost-effectiveness, barriers, and facilitators. BMC Prim Care. 2022;23(1):298. Crossref
• Bin Rakhis SA Sr, AlDuwayhis NM, Aleid N, AlBarrak AN, Aloraini AA. Glycemic control for type 2 diabetes mellitus patients: a systematic review. Cureus. 2022;14(6):e26180. Crossref
• Zhao Q, Li H, Ni Q, Dai Y, Zheng Q, Wang Y, et al. Follow-up frequency and clinical outcomes in patients with type 2 diabetes: a prospetive analysis based on multicenter real-world data. J Diabetes. 2022;14(5):306-314. Crossref
• Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: the MUSCLES-DM study. J Am Med Dir Assoc. 2021;22(4):834-838. Crossref
• Hurst CP, Rakkapao N, Hay K. Impact of diabetes self-management, diabetes management self-efficacy and diabetes knowledge on glycemic control in people with type 2 diabetes (T2D): a multi-center study in Thailand. PLoS One. 2020;15(12):e0244692. Crossref
• Koo BK, Moon S, Moon MK. Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study. BMC Geriatr. 2021;21(1):684. Crossref
• Kosjerina V, Parsa M, Scheuer SH, Ankarfeldt MZ, Sørensen KK, Brock B, et al. Comparative cardiovascular effectiveness of newer glucose-lowering drugs in elderly with type 2 diabetes: a target trial emulation cohort study. Lancet Reg Health Eur. 2025;40:100923. Crossref